Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Certa Therapeutics is a Biotechnology Research brand in Melbourne. It is privately held, and its site is certatherapeutics.com. It holds one address on record, all in Australia. Headcount on record is 9. One Australian registration (ABN) is a confirmed match. Its latest round on record is Grant, US$19.1M. It is listed alongside eight similar brands, mostly in Biotechnology Research.
certatherapeutics.com LinkedIn
ABN22622894320
| CERTA THERAPEUTICS PTY LTD | ABN 22622894320 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Certa Therapeutics is a biotechnology company focused on improving lives by developing innovative precision treatments for inflammatory and fibrotic diseases.
| Countries | 1 |
|---|
All codes: AU
| Rounds | 1 |
|---|---|
| Axis | 2018 to 2026 |
| Grant · 4 Jul 2018 | US$ 19.1M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One Victoria entity on the ABR: CERTA THERAPEUTICS PTY LTD (ABN 22 622 894 320), high confidence.
9 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
One address on record, Australia only.
One round. Latest 4 July 2018: grant, US$19,100,000, investor Brandon Capital Partners.
7 profiles list Certa Therapeutics as a peer — 73rd percentile in Biotechnology Research. It lists ten peers of its own. CBE and OccuRx list it back.